“In an even more worrisome development, when vaccinated but previously uninfected people suffer breakthrough Omicron infections, their T-cell response is biased toward earlier versions of Sars-Cov-2 - not to the Omicron variant that has actually infected them.”
“The aetiology of this severe acute hepatitis remains unknown and is being investigated.”
“For many of the confirmed cases, health officials don't know how the person caught the virus. Those infected haven't traveled or come into contact with another infected person. That means the virus is spreading in some communities and cities, cryptically.”
https://www.npr.org/sections/health-shots/2022/06/25/1107416457/monkeypox-outbreak-in-us
“Thought to be the worst ever outbreak in the UK, much of the drama is unfolding offshore; the true toll in those remote colonies, where birds crowd tightly together, is not yet fully known.”
“Lab studies consistently suggest that antibodies triggered by vaccination are less effective at blocking BA.4 and BA.5 than they are at blocking earlier Omicron strains, including BA.1 and BA.2. This could leave even vaccinated and boosted people vulnerable to multiple Omicron infections, scientists say.”
https://www.nature.com/articles/d41586-022-01730-y
“Medical centers (in Israel) have reported an increase in hospitalized patients, those who are seriously ill and the number who have died.”
https://www.jpost.com/health-and-wellness/article-710525
“It is the first time the panel has proposed that vaccine makers modify the shots to target a different variant. The FDA will likely accept the committee’s recommendation and authorize a vaccine change. However, the panel did not make a recommendation on which omicron subvariant the shots should target.”
Prof Spector added: “This Omicron BA.5 variant is particularly good at immune escape, causing an increase in reinfections in people in spite of vaccines and natural immunity.”
https://www.the-sun.com/health/5674230/uk-covid-cases-heading-for-record-high-zoe/
Geert Vanden Bossche received his DVM from the University of Ghent, Belgium, and his PhD degree in Virology from the University of Hohenheim, Germany. He held adjunct faculty appointments at universities in Belgium and Germany. After his career in Academia, Geert joined several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to serve various roles in vaccine R&D as well as in late vaccine development.
Geert then moved on to join the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as Senior Program Officer; he then worked with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager. At GAVI he tracked efforts to develop an Ebola vaccine. He also represented GAVI in fora with other partners, including WHO, to review progress on the fight against Ebola and to build plans for global pandemic preparedness.
Back in 2015, Geert scrutinized and questioned the safety of the Ebola vaccine that was used in ring vaccination trials conducted by WHO in Guinea. His critical scientific analysis and report on the data published by WHO in the Lancet in 2015 was sent to all international health and regulatory authorities involved in the Ebola vaccination program. After working for GAVI, Geert joined the German Center for Infection Research in Cologne as Head of the Vaccine Development Office. He is at present primarily serving as a Biotech / Vaccine consultant while also conducting his own research on Natural Killer cell-based vaccines.
Email: info@voiceforscienceandsolidarity.org
.svg){kind=small}
